Brain Maturation and Sleep

NCT ID: NCT02685891

Last Updated: 2024-01-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

90 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-06-30

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this study, the investigator evaluates whether there are age-specific diurnal changes in markers of cortical plasticity in children, adolescents and adults. The question will be investigated by the quantification of brain metabolites and structural brain volumes using magnet resonance imaging (MRI) and electrophysiological markers using sleep encephalography (sleep EEG). In a second step, it will be tested how these markers of cortical plasticity change depending on a modulation of sleep by applying tones during deep sleep.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Given that children and adolescents undergo entirely different maturational processes (children show an increase, adolescents a decrease in synapse density) larger diurnal changes in children are expected compared to adolescents concerning brain metabolites and structural markers. These cortical changes in synapse density are thought to be reflected in electrophysiological markers in the sleep EEG (children show a higher slow wave activity, adolescents a reduced slow wave activity). With the modulation of the deep (slow wave) sleep by playing short, low volume tones, the investigators want to test if there is a causal relationship between slow wave sleep and markers of cortical plasticity.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

playing tones

During slow-wave sleep short tones (50ms, 50dB) will be played

Group Type ACTIVE_COMPARATOR

Playing tones during deep sleep

Intervention Type OTHER

Playing tones time locked to slow waves (Duration:50ms, volume: 50dB)

Playing no tones

During slow-wave sleep no tones will be played

Group Type SHAM_COMPARATOR

sham condition

Intervention Type OTHER

in the sham condition, no tones will be played

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Playing tones during deep sleep

Playing tones time locked to slow waves (Duration:50ms, volume: 50dB)

Intervention Type OTHER

sham condition

in the sham condition, no tones will be played

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male and female subjects 8 to 30 years of age,
* good general health Status
* right-handedness,
* Written informed consent after participants' information

Exclusion Criteria

* sleep disorders (insomnia, sleep disordered breathing, restless legs syndrome)
* sleep complaints in general
* irregular sleep-wake rhythm
* daytime sleep
* travelling across a time zone within the last month
* diseases or lesions of the central nervous system
* psychiatric diseases
* learning disability
* skin allergy or very sensitive skin
* acute pediatric disease
* pregnancy
* drug and medication use and abuse
* nicotine use
* high caffeine consumption (\>2 servings/day (\>160 mg caffeine); including coffee, tea, white and dark chocolate, coca cola, energy drink)
* Alcohol consumption in children and adolescents under 16 years
* high alcohol consumption in adults (\> 1 standard serving/day (\>14 mg Alcohol))
* high alcohol consumption in adolescents aged 16 years and above (\> 3-4 Standard servings per week)
Minimum Eligible Age

8 Years

Maximum Eligible Age

30 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Children's Hospital, Zurich

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Children's Hospital Zurich

Zurich, , Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PB_2016-00254

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Cerebral MRI During Sleep
NCT03304652 COMPLETED